Table 1.
n(%) | Total | |
Gender: male | 157(45.0) | 349 |
WAZ<-2 | 154(47.8) | 322 |
HIV antibody +ve | 215(60.6) | 355 |
HIV DNA PCR +ve | 203(57.2) | 355 |
2–6months(HIV+) | 125(61.0) | 205 |
7–11months(HIV+) | 37(50.2) | 74 |
13–18months(HIV+) | 41(53.9) | 6 |
n(%) | Total | |
Gender: male | 157(45.0) | 349 |
WAZ<-2 | 154(47.8) | 322 |
HIV antibody +ve | 215(60.6) | 355 |
HIV DNA PCR +ve | 203(57.2) | 355 |
2–6months(HIV+) | 125(61.0) | 205 |
7–11months(HIV+) | 37(50.2) | 74 |
13–18months(HIV+) | 41(53.9) | 6 |